The latest pharma news from Brazil, including the partnership between Biophytis and Innovation Solutions Pharma; Merck's 100 years in Brazil;…

The latest pharma industry news from Germany, including Lilly's new German plant; Bayer's aborted anti-clotting drug trial and legal worries;…

A roundup of some of the latest news from Chinese pharma including CanSino's Gates Foundation grant for polio vaccine R&D; Merck's deal with…

Morocco is undergoing ambitious reforms, extending universal healthcare coverage to all its citizens while resolving the shortcomings laid bare during…

Could the UK’s re-joining of Horizon Europe, the EU’s EUR 95 billion research funding programme, be the latest sign that the country is ready to…

Merck Morocco's Ahmad ALMWAKEH feels that the winds of change are blowing in the right direction across Moroccan healthcare, with a well-defined…

Merck’s Kaushal Kishore attempts to illustrate why pharma companies have struggled to crack what he calls "the Gross to Net (GtN) code." He outlines…

The latest from Mexican pharma, including the distribution agreement between Dow and Azelis, Neuraxpharm's new LatAm subsidiaries in Mexico and…

Merck KGaA's Marco Rauland and Kaushal Kishore examine how artificial intelligence and machine learning can best be applied in pharmaceutical pricing…

A roundup of some of the biggest recent stories coming out of China, including the commerce minister's peace offering to international drug companies;…

A roundup of some of the most important recent stories from the burgeoning South Korean pharma and biotech industry, including a government plan to…

The latest pharma news from Brazil, including Daiichi Sankyo's new plant; Bristol Myers Squibb's re-entry into Brazil's cardiology market; the Anvisa…